Latest Strategic Projects News

Podium Minerals has launched a A$12 million capital raising to accelerate development at its Parks Reef platinum group metals project, following a key metallurgical breakthrough and resource upgrades.

Mont Royal Resources Ltd has lodged a replacement prospectus to raise between A$8 million and A$10 million, supporting its merger with Commerce Resources Corp and advancing critical minerals projects in Quebec, Canada.

Beonic Ltd has raised $4.27 million through convertible notes to fund its product development, repay upcoming debt, and advance its North African Airport Project.

Auravelle Resources reports standout high-grade gold results from its South Australian projects and outlines a robust exploration agenda targeting major gold deposits nearby.

Summit Minerals announces a $1.67 million capital raise through a Placement and a fully underwritten Rights Issue, aiming to accelerate exploration in Brazil and pursue new project opportunities.

BPM Minerals has secured a Heritage Agreement with traditional owners at its Forelands Gold Project, clearing the way for a maiden drilling program targeting high-grade gold prospects. The company’s strengthened balance sheet and expert team set the stage for a promising exploration phase.

Enova Mining has narrowed its half-year loss to $1.07 million while progressing key rare earth and lithium projects in Brazil and Australia, supported by recent capital raises totaling $2.35 million.

Great Northern Minerals has significantly expanded its Catalyst Ridge rare earth and antimony project in California’s Mountain Pass District by applying for 96 additional lode claims, positioning itself strongly within a critical US minerals hub.

Euro Manganese Inc. reports significant progress on its Chvaletice Project and Bécancour Plant, positioning itself as a key Western supplier of high-purity manganese critical for EV batteries. The company highlights strong feasibility results, strategic financing partnerships, and multiple offtake agreements amid an expected global supply deficit.

Chimeric Therapeutics reported a reduced net loss of $10.43 million for FY2025, driven by cost efficiencies and strategic project reprioritisation, while making significant clinical progress in its CAR T-cell and NK cell therapy programs.

DTI Group Ltd reported an 11% revenue increase and secured a $4 million Adelaide Metro contract, alongside a $2.69 million capital raise to fuel growth. The company also deepened global partnerships and enhanced its technology platform during FY25.

Ava Group Limited reported solid FY25 results with 5% revenue growth to $31.7 million and a turnaround to positive EBITDA of $2.1 million, underpinned by strong demand for its Aura Ai-X security solutions and a robust $88 million sales pipeline.